Concepedia

Author

David Vanda

Palacký University OlomoucORCID

Also Known As

David Vanda

8

Publications

212

Citations

6

H-Index

20

Concepts

All Affiliations

Palacký University OlomoucInstitute of Molecular and Translational MedicineJagiellonian UniversityInsermUniversité de Montpellier
DV

About

David Vanda is an author at Palacký University Olomouc specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

100

2

Natural Sciences

1

1

15

3

Biochemistry

1

1

15

4

Biomolecular Engineering

1

1

15

5

Immunology

1

1

25

David Vanda

×

5

Publications

121

Citations

5

H-Index

YearCitations

Novel non-sulfonamide 5-HT 6 receptor partial inverse agonist in a group of imidazo[4,5- b ]pyridines with cognition enhancing properties

David Vanda, Miroslav Soural, Vittorio Canale,

European Journal of Medicinal Chemistry

2017

46

New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases

Veronika Ručilová, Artur Świerczek, David Vanda,

European Journal of Medicinal Chemistry

2020

25

Imidazopyridine-Based 5-HT<sub>6</sub> Receptor Neutral Antagonists: Impact of <i>N</i><sup>1</sup>-Benzyl and <i>N</i><sup>1</sup>-Phenylsulfonyl Fragments on Different Receptor Conformational States

David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel,

Journal of Medicinal Chemistry

2021

21

Synthesis of Novel N<sup>9</sup>-Substituted Purine Derivatives from Polymer Supported α-Amino Acids

David Vanda, Radek Jorda, Barbora Lemrová,

ACS Combinatorial Science

2015

15

1,4,6-Trisubstituted imidazo[4,5-c]pyridines as inhibitors of Bruton’s tyrosine kinase

Soňa Krajčovičová, Radek Jorda, David Vanda,

European Journal of Medicinal Chemistry

2020

14

Page 1